Effects of myosin heavy chain manipulation in experimental heart failure

Journal of Molecular and Cellular Cardiology

Volumn 48, Issue 5, 2010, Pages 999-1006

  James, Jeanne ^a   Hor, Kan ^a   Moga, Michael Alice ^b   Martin, Lisa Ann ^a   Robbins, Jeffrey ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Heart failure; Left ventricular pressure overload; Myocardial infarction; Myosin heavy chain; Transgenic rabbits

Indexed keywords

ISOPROTEIN; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DOWN REGULATION; EXPERIMENTAL RABBIT; GENETIC MANIPULATION; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE OVERLOAD; HEART PROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HEART FAILURE; MALE; MYOCARDIAL INFARCTION; MYOSIN HEAVY CHAINS; POLYMERASE CHAIN REACTION; PROTEIN ISOFORMS; RABBITS; TACHYCARDIA; VENTRICULAR DYSFUNCTION, LEFT;

ORYCTOLAGUS CUNICULUS;

EID: 77951622372     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2009.10.013     Document Type: Article

References (27)

1. VanBuren P., Harris D.E., Alpert N.R., Warshaw D.M. Cardiac V1 and V3 myosins differ in their hydrolytic and mechanical activities in vitro. Circ. Res. 1995, 77:439-444.
2. Alpert N.R., Mulieri L.A. Determinants of energy utilization in the activated myocardium. Fed. Proc. 1986, 45:2597-2600.
3. Alpert N.R., Mulieri L.A. Functional consequences of altered cardiac myosin isoenzymes. Med. Sci. Sports Exerc. 1986, 18:309-313.
4. Harris D.E., Work S.S., Wright R.K., Alpert N.R., Warshaw D.M. Smooth, cardiac and skeletal muscle myosin force and motion generation assessed by cross-bridge mechanical interactions in vitro. J. Muscle Res. Cell. Motil. 1994, 15:11-19.
5. Sugiura S., Yamashita H. Functional characterization of cardiac myosin isoforms. Jpn. J. Physiol. 1998, 48:173-179.
6. Lowes B.D., Minobe W., Abraham W.T., Rizeq M.N., Bohlmeyer T.J., Quaife R.A., et al. Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J. Clin. Invest. 1997, 100:2315-2324.
7. Nakao K., Minobe W., Roden R., Bristow M.R., Leinwand L.A. Myosin heavy chain gene expression in human heart failure. J. Clin. Invest. 1997, 100:2362-2370.
8. Miyata S., Minobe W., Bristow M.R., Leinwand L.A. Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ. Res. 2000, 86:386-390.
9. Herron T.J., McDonald K.S. Small amounts of alpha-myosin heavy chain isoform expression significantly increase power output of rat cardiac myocyte fragments. Circ. Res. 2002, 90:1150-1152.
10. Tardiff J.C., Hewett T.E., Factor S.M., Vikstrom K.L., Robbins J., Leinwand L.A. Expression of the beta (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects. Am. J. Physiol. Heart Circ. Physiol. 2000, 278:H412-419.
11. Bers D.M. Calcium fluxes involved in control of cardiac myocyte contraction. Circ. Res. 2000, 87:275-281.
12. James J., Martin L., Krenz M., Quatman C., Jones F., Klevitsky R., et al. Forced expression of alpha-myosin heavy chain in the rabbit ventricle results in cardioprotection under cardiomyopathic conditions. Circulation 2005, 111:2339-2346.
13. Burton F.L., McPhaden A.R., Cobbe S.M. Ventricular fibrillation threshold and local dispersion of refractoriness in isolated rabbit hearts with left ventricular dysfunction. Basic Res. Cardiol. 2000, 95:359-367.
14. Lindsey M.L., Gannon J., Aikawa M., Schoen F.J., Rabkin E., Lopresti-Morrow L., et al. Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction. Circulation 2002, 105:753-758.
15. White D.C., Hata J.A., Shah A.S., Glower D.D., Lefkowitz R.J., Koch W.J. Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:5428-5433.
16. Friehs I., Cao-Danh H., Nathan M., McGowan F.X., del Nido P.J. Impaired insulin-signaling in hypertrophied hearts contributes to ischemic injury. Biochem. Biophys. Res. Commun. 2005, 331:15-22.
17. Friehs I., Moran A.M., Stamm C., Choi Y.H., Cowan D.B., McGowan F.X., et al. Promoting angiogenesis protects severely hypertrophied hearts from ischemic injury. Ann. Thorac. Surg. 2004, 77:2004-2010. discussion 2011.
18. Stamm C., Friehs I., Cowan D.B., Moran A.M., Cao-Danh H., Duebener L.F., et al. Inhibition of tumor necrosis factor-alpha improves postischemic recovery of hypertrophied hearts. Circulation 2001, 104:I350-I355.
19. Podesser B., Wollenek G., Seitelberger R., Siegel H., Wolner E., Firbas W., et al. Epicardial branches of the coronary arteries and their distribution in the rabbit heart: the rabbit heart as a model of regional ischemia. Anat. Rec. 1997, 247:521-527.
20. Suzuki T, Palmer B, James J, Wang Y, Chen Z, VanBuren P, et al. Effects of cardiac myosin isoform variation on myofilament function and cross-bridge kinetics in transgenic rabbits. Circ Heart Fail 2009;2(4):334-41.
21. James J., Sanbe A., Yager K., Martin L., Klevitsky R., Robbins J. Genetic manipulation of the rabbit heart via transgenesis. Circulation 2000, 101:1715-1721.
22. Hoh J.F., McGrath P.A., Hale P.T. Electrophoretic analysis of multiple forms of rat cardiac myosin: effects of hypophysectomy and thyroxine replacement. J. Mol. Cell. Cardiol. 1978, 10:1053-1076.
23. Martin A.F., Rabinowitz M., Blough R., Prior G., Zak R. Measurements of half-life of rat cardiac myosin heavy chain with leucyl-tRNA used as precursor pool. J. Biol. Chem. 1977, 252:3422-3429.
24. Morkin E., Kimata S., Skillman J.J. Myosin synthesis and degradation during development of cardiac hypertrophy in the rabbit. Circ. Res. 1972, 30:690-702.
25. Hayashi Y., Takeuchi M., Takaoka H., Hata K., Mori M., Yokoyama M. Alteration in energetics in patients with left ventricular dysfunction after myocardial infarction: increased oxygen cost of contractility. Circulation 1996, 93:932-939.
26. Katz A.M. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N. Engl. J. Med. 1990, 322:100-110.
27. Ingwall J.S., Weiss R.G. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ. Res. 2004, 95:135-145.